Biotech

Companies & Industries

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 02.11.2022.

#diagnostics
#PharmaScrip
#disease
#rna
#therapy
#Genomics
#oncology
#research
#Biobanking
#Cryogenic

@KBIBiopharma shared
On Oct 31, 2022
Abdelaziz Toumi, Ph.D., today joins KBI Biopharma and Selexis SA as Chief Business Officer. Toumi brings more than two decades of global expertise in biotech, pharmaceutical, and CDMO industries, demonstrating visionary and strategic leadership. https://t.co/N3ZtZnxCDh
Open
KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business Officer

KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business Officer

KBI Biopharma, Inc. (KBI) and Selexis SA (Selexis) today announced that Abdelaziz Toumi, Ph.D., will begin serving as the companies’ Chief Business Officer.

@ReutersScience shared
On Oct 26, 2022
A government panel has approved an application seeking environmental clearance of indigenously developed genetically modified (GM) mustard seeds, experts said, paving the way for commercial use of the country's first GM food crop. https://t.co/OSUtXrhdYq
Open
India gives environmental clearance for genetically modified mustard

India gives environmental clearance for genetically modified mustard

A government panel has approved an application seeking environmental clearance of indigenously developed genetically modified (GM) mustard seeds, experts said, paving the way for commercial ...

@BiotechWorld shared
On Nov 2, 2022
Freenome Adds Several Community Partners to Clinical Study for the Detection of Cancer, Expanding Reach and Representation https://t.co/1tRL3t29bv
Open
Freenome Adds Several Community Partners to Clinical Study for the Detection of Cancer, Expanding Reach and Representation

Freenome Adds Several Community Partners to Clinical Study for the Detection of Cancer, Expanding Reach and Representation

Freenome Adds Several Community Partners to Clinical Study for the Detection of Cancer, Expanding Reach and Representation - read this article along with other careers information, tips and ...

@BiotechWorld shared
On Nov 2, 2022
AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at World Immunotherapy Congress Europe https://t.co/7bKkc49s3G
Open
AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at World Immunotherapy Congress Europe

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at World Immunotherapy Congress Europe

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at World Immunotherapy Congress Europe - read this article along with other careers information, tips and advice on BioSpace

@PharmaScrip shared
On Oct 31, 2022
Santhera Finalizes Vamorolone Filings And Now Seeks Funds https://t.co/JpKAijSWkZ #PharmaScrip
Open
Santhera Finalizes Vamorolone Filings And Now Seeks Funds

Santhera Finalizes Vamorolone Filings And Now Seeks Funds

<p>The Swiss biotech is hoping that its Duchenne muscular dystrophy prospect, vamorolone, will get on the FDA fast track to approval but acknowledges that getting more funds is an urgent ...

@biobankingcom shared
On Oct 29, 2022
#Biobanking of surplus human healthy and #disease-derived tissues is essential for #diagnostics and translational research. Read more: https://t.co/n4tvoVZU7V #biobank #Cryopreservation #Cryogenic #freezing #cancer #tumor #oncology #therapy #Genomics #rna #research #DNA @Nature
Open
Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq

Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq

Fresh vs. slow-frozen tissues from various malignancies are compared for the establishment of 2D, 3D and ex vivo cultures, as well as for scRNAseq analysis, and found to be comparable and ...

@pharmaphorum shared
On Oct 28, 2022
Swiss #biotech @Santhera and partner ReveraGen complete a rolling NDA for dissociative steroid vamorolone in #Duchenne muscular dystrophy, seeking a six-month review https://t.co/XBYE2FkNVf
Open
Santhera seeks speedy FDA review of Duchenne drug vamorolone

Santhera seeks speedy FDA review of Duchenne drug vamorolone

Swiss biotech Santhera and partner ReveraGen complete a rolling NDA for dissociative steroid vamorolone in Duchenne muscular dystrophy, seeking a six-month review

@NatureBiotech shared
On Nov 1, 2022
Programmable RNA-sensing technology enables manipulation of specific cell type #NBTintheNews via @ScienceBoard https://t.co/Wk9ftvHRB7
Open
Programmable RNA-sensing technology enables manipulation of specific cell type

Programmable RNA-sensing technology enables manipulation of specific cell type

Researchers have developed a programmable RNA-sensing technology that triggers the production of a payload protein when it encounters specific cell types, with potential applications in ...

Read more:
weekly 02.11.2022
View archives
Back to home

Subscribe to Biotech - Companies & Industries.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Companies & Industries.
Privacy Policy

Sign up for the weekly Biotech - Companies & Industries newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Companies & Industries weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy